Compounds > doxifluridine
Page last updated: 2024-08-22

doxifluridine and Cancer of Head

doxifluridine has been researched along with Cancer of Head in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciccolini, J; Dubreuil, A; Etienne, MC; Fischel, JL; Formento, JL; Formento, P; Magné, N; Marchetti, S; Milano, G; Renée, N; Tiffon, C1
Abele, R; Cavalli, F; Grossenbacher, R; Kaplan, E; Schmid, HJ1
Braakhuis, BJ; de Bruijn, EA; Laurensse, EJ; Peters, GJ; Pinedo, HM; van Walsum, M1
Braakhuis, BJ; Laurensse, EJ; Peters, GJ; Pinedo, HM1
Irie, K; Kawahara, T; Okajima, K; Sakai, K; Satomi, T; Taguchi, T; Terasawa, T; Tomita, K; Yamaguchi, A; Yamamoto, M1

Other Studies

5 other study(ies) available for doxifluridine and Cancer of Head

ArticleYear
ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-15, Volume: 9, Issue:13

    Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Deoxycytidine; DNA Primers; Floxuridine; Fluorouracil; Gefitinib; Head and Neck Neoplasms; Humans; Models, Chemical; Polymerase Chain Reaction; Pyrimidines; Quinazolines; RNA; RNA, Messenger; Time Factors; Transcription, Genetic

2003
Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neck.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:3

    Topics: Aged; Antineoplastic Agents; Bone Marrow Diseases; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine; Head and Neck Neoplasms; Humans; Male; Middle Aged

1984
Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
    British journal of cancer, 1989, Volume: 59, Issue:3

    Topics: Animals; Antineoplastic Agents; Carcinoma; Colonic Neoplasms; Drug Resistance; Female; Floxuridine; Fluorouracil; Head and Neck Neoplasms; Isomerism; Mice; Mice, Nude; Neoplasm Transplantation; Pentosyltransferases; Pyrimidine Phosphorylases

1989
Fluoropyrimidine metabolism in human head and neck cancer xenografts and murine colon tumors.
    Advances in experimental medicine and biology, 1989, Volume: 253B

    Topics: Animals; Colonic Neoplasms; Drug Screening Assays, Antitumor; Floxuridine; Fluorouracil; Head and Neck Neoplasms; Humans; Mice; Neoplasm Transplantation; Orotate Phosphoribosyltransferase; Pentosyltransferases; Pyrimidine Phosphorylases; Tumor Cells, Cultured

1989
[Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:11

    Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Diarrhea; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nausea; Neoplasms; Rectal Neoplasms; Stomach Neoplasms

1985